Lechaux D, Trebuchet G, Le Calve J L
Département de Chirurgie Viscérale, Hôpital Pontchaillou, Rue Henri Le Guilloux 35033 Rennes, France.
Surg Endosc. 2002 Oct;16(10):1409-12. doi: 10.1007/s00464-002-9011-7. Epub 2002 Jul 29.
The purpose of this study was to evaluate the 5-year survival of 206 consecutive patients with left colon carcinoma operated with a laparoscopic procedure between March 1992 and December 2000.
Patients with obstructing or bulky cancers were excluded from this study. Tumor stage was defined according to the Dukes modified classification. The laparoscopic-assisted technique included primary high vascular ligation, centrifugal dissection of the mesentery, and "no touch" technique. The survival rates were calculated with the Kaplan-Meier test.
There were 109 males and 97 females, median age 67 (range 34-91). There were 30 left hemicolectomies (15%) and 177 sigmoid colectomies (85%). 22 patients required open conversion (11%). Overall operative mortality (1 month) was 1% and morbidity 12% (surgical and medical). There were 56 Dukes A carcinomas (27%), 69 Dukes B (34%), 54 Dukes C (26%), and 27 Dukes D (13%). 125 patients (61%) are alive and disease free, 22 (11%) are alive with disease recurrence, and 59 patients (28%) are deceased. None have been lost to follow-up. Only 1 case of trocar site implantation occurred after curative resections. Three-year observed survival rate were 93% for Dukes A + B (node negative tumors confined to the bowel wall), 78% for Dukes C, and 15% for Dukes D. The 5-year survival rates were 85% for Dukes A + B, 61% for Dukes C, and 8% for Dukes D.
Laparoscopic colectomy for cancer seems to be a safe procedure. The long-term results are comparable to those of open surgery. Further randomized trials will be necessary to confirm the value of this technique.
本研究旨在评估1992年3月至2000年12月期间连续206例行腹腔镜手术的左结肠癌患者的5年生存率。
本研究排除了患有梗阻性或巨大癌的患者。肿瘤分期根据Dukes改良分类法确定。腹腔镜辅助技术包括原发性高位血管结扎、肠系膜离心性分离和“不接触”技术。生存率采用Kaplan-Meier检验计算。
男性109例,女性97例,中位年龄67岁(范围34 - 91岁)。行左半结肠切除术30例(15%),乙状结肠切除术177例(85%)。22例患者需要转为开腹手术(11%)。总体手术死亡率(1个月)为1%,发病率为12%(手术和内科)。有56例Dukes A期癌(27%),69例Dukes B期(34%),54例Dukes C期(26%),27例Dukes D期(13%)。125例患者(61%)存活且无疾病,22例(11%)存活但有疾病复发,59例患者(28%)死亡。无一例失访。根治性切除术后仅发生1例套管针穿刺部位种植。Dukes A + B期(局限于肠壁的无淋巴结转移肿瘤)的3年观察生存率为93%,Dukes C期为78%,Dukes D期为15%。5年生存率Dukes A + B期为85%,Dukes C期为61%,Dukes D期为8%。
腹腔镜结肠癌切除术似乎是一种安全的手术。长期结果与开放手术相当。需要进一步的随机试验来证实该技术的价值。